In article <millertj-2710970834520001 at millermac.es.dupont.com>, millertj at esvax.dnet.dupont.com (T Miller) writes:
>David, can you elaborate as to how GCG crippled the product? Was it only
>because source code was an extra-cost option with version 9?
Yes, that's what I meant. Also it wasn't clear at the time we dropped it
whether there would ever be access to the really low level stuff even with
the extra-cost support. This must have been resolved since then, but I
don't know what the result was.
Regards,
David Mathog
mathog at seqaxp.bio.caltech.edu
Manager, sequence analysis facility, biology division, Caltech
